Navigation Links
MiMedx To Present At 33rd Annual Canaccord Genuity Growth Conference
Date:8/5/2013

MARIETTA, Ga., Aug. 5, 2013 /PRNewswire/ -- MiMedx Group, Inc.  (NASDAQ: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today that it will present at the 33rd Annual Canaccord Genuity Growth Conference in Boston.  Parker H. "Pete" Petit, Chairman and CEO, William C. Taylor, President and COO, and Michael J. Senken, Chief Financial Officer, are scheduled to present on August 14th at 11:30 a.m. EDT at the InterContinental Boston.  A webcast of this presentation will be available on the Company's website, www.mimedx.com

About the Company
MiMedx® is an integrated developer, manufacturer and marketer of patent protected regenerative biomaterial products and bioimplants processed from human amniotic membrane. "Innovations in Regenerative Biomaterials" is the framework behind our mission to give physicians products and tissues to help the body heal itself. Our biomaterial platform technologies include the device technologies HydroFix® and CollaFix™, and our tissue technologies, AmnioFix® and EpiFix®. Our tissue technologies are processed from human amniotic membrane that is derived from the donated placentas. Through our donor program, mothers delivering full-term Caesarean section births can elect in advance of delivery to donate the placenta in lieu of having it discarded as medical waste. We process the human amniotic membrane utilizing our proprietary PURION® process, to produce a safe, effective and minimally manipulated implant for homologous use. MiMedx® is the leading supplier of amniotic tissue, having supplied over 160,000 allografts to date
'/>"/>

SOURCE MiMedx Group, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Mimedx Scientific Study Is Electronically Published in The International Wound Journal
2. MiMedx Announces Record Second Quarter Results
3. BioTech Companies in the News - Alliqua, Transition Therapeutics, Organovo, MiMedx Group, Keryx Biopharmaceuticals
4. MiMedx To Exceed High End Of Second Quarter Guidance
5. MiMedx to Ring NASDAQ Stock Market Opening Bell
6. MiMedx to Present at Jefferies 2013 Global Healthcare Conference
7. MiMedx Secures a $3.0 Million Revolving Line of Credit with Bank of America
8. MiMedx Announces Record First Quarter 2013 Results
9. MiMedx Group, Inc. Announces Listing on the NASDAQ Capital Market
10. MiMedx Group, Inc. Announces Release Date for 2013 First Quarter Results
11. MiMedx Responds To Inquiries Regarding Trading Activity; Reiterates First Quarter And Full Year Goals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... -- Research and Markets ( ... PharmaBiotech,s new report "DNA Sequencing - Technologies, ... This report briefly reviews basics of human ... applications. Current large and small sequencers are described ... of sequencing are described including those for genetics, ...
(Date:9/2/2015)... , Sep. 02, 2015 ... has announced the addition of Jain PharmaBiotech,s new ... to their offering. This report ... a characteristic that can be objectively measured and ... pathogenic processes as well as pharmacological responses to ...
(Date:9/2/2015)... 2015 Biovista Inc. is glad ... 2015 BeHEARD science challenge, a global competition hosted by ... access to the latest life science innovations and technologies. ... pathway analytics capability to support Steven Laffoon ... study of Niemann-Pick Disease Type A (NPA), a rare ...
(Date:9/2/2015)... -- Australian prostate cancer technology company Minomic International Ltd ... ,outstanding, science that uses its patented antibody. ... prostate cancer diagnostic test known as MiCheck® next year, ... the peer-reviewed Australian Museum Eureka Science Prize for ... prize is awarded for ground breaking research that has ...
Breaking Biology Technology:Global DNA Sequencing Technologies Report 2015: Profiles of 130 Companies Involved in Sequencing and their 140 Collaborations 2Updated 2015 Biomarkers Report - Latest Technologies, Markets and Companies Insights to 2024 with over 1,000 References 2Updated 2015 Biomarkers Report - Latest Technologies, Markets and Companies Insights to 2024 with over 1,000 References 3Biovista Sponsors Wylder Nation Foundation's Research on Acid Sphingomyelinase Deficiency 2Prostate Cancer Company Minomic Wins Prestigious Eureka Science Prize 2Prostate Cancer Company Minomic Wins Prestigious Eureka Science Prize 3
... Masimo (Nasdaq: MASI ) ... accuracy and value of its noninvasive and continuous hemoglobin ... the Society of Critical Care Medicine (SCCM) Annual ... multi-professional critical care event of the year, the SCCM ...
... Soligenix, Inc. (OTC Bulletin Board: SNGX ... announced today that the US Food and Drug Administration ... the prevention of ricin intoxication.  RiVax™ is a proprietary ... chain of ricin toxin which induces ricin neutralizing antibodies ...
... new image and cell technologies have for the first ... red blood cells. The researchers, from the Walter and ... of Technology, Sydney (UTS), achieved this long-held aim using ... a technology platform new to Australia. The detailed ...
Cached Biology Technology:New Clinical Study Finds Masimo Noninvasive Hemoglobin Accurate in Patients with Critically Low Hemoglobin Levels 2New Clinical Study Finds Masimo Noninvasive Hemoglobin Accurate in Patients with Critically Low Hemoglobin Levels 3New Clinical Study Finds Masimo Noninvasive Hemoglobin Accurate in Patients with Critically Low Hemoglobin Levels 4New Clinical Study Finds Masimo Noninvasive Hemoglobin Accurate in Patients with Critically Low Hemoglobin Levels 5Soligenix Receives FDA Orphan Drug Designation for RiVax™ for the Prevention of Ricin Intoxication 2Soligenix Receives FDA Orphan Drug Designation for RiVax™ for the Prevention of Ricin Intoxication 3Soligenix Receives FDA Orphan Drug Designation for RiVax™ for the Prevention of Ricin Intoxication 4Soligenix Receives FDA Orphan Drug Designation for RiVax™ for the Prevention of Ricin Intoxication 5Soligenix Receives FDA Orphan Drug Designation for RiVax™ for the Prevention of Ricin Intoxication 6Malaria parasite caught red-handed invading blood cells 2Malaria parasite caught red-handed invading blood cells 3
(Date:8/5/2015)... -- According to a new market research ... Vertical (BFSI, Airport, IT & Telecom, Utilities, Education, Defense ... 2020", published by MarketsandMarkets, defines and segments the Physical ... The global PIAM Market is estimated to grow from ... at a CAGR of 14.9 % from 2014 to ...
(Date:8/4/2015)... DUBLIN , Aug. 04, 2015 /PRNewswire/ ... ( http://www.researchandmarkets.com/research/nvh7k2/digital_forensics ) has announced the addition ... Component (Hardware, Software, and Service), Sub-Segment (Computer ... Cloud Forensics), Tool Types, Service, Vertical and ... report to their offering. By ...
(Date:7/31/2015)... Den 10. internationale konference om Genomik (ICG-10, ... - 25. oktober i Shenzhen , ... i år. Siden starten i 2006 er ICB blevet ... og er en af de mest dynamiske, entusiastiske og ... nylige gennembrud og fremskridt inden for ,omik,-forskning, som yderligere ...
Breaking Biology News(10 mins):Physical Identity and Access Management Market Worth $546.2 Million by 2019 2Physical Identity and Access Management Market Worth $546.2 Million by 2019 3Physical Identity and Access Management Market Worth $546.2 Million by 2019 4Digital Forensics Market - The Market Represents a Compound Annual Growth Rate (CAGR) of 11.3% From 2015 to 2020 2Den 10. internationale konference om Genomics (ICG-10) åbner i oktober 2
... who held their breath for several minutes had elevated levels ... a new study from the Journal of Applied Physiology ... and leaves open the question of whether lengthy apnea (breath-holding) ... "The results indicate that prolonged, voluntary apnea affects the integrity ...
... Peter Wilf, associate professor of geosciences, has been ... 2012 by the Paleontological Society. The Paleontological ... other work in paleontology is highly regarded and ... The Lecturers are excellent speakers who communicate the ...
... (August 3, 2009) La Jolla Institute for Allergy ... a role in allergy onset, instead have discovered its ... be important in myeloproliferative diseases and some types of ... disorders characterized by an overproduction of blood cells by ...
Cached Biology News:Holding breath for several minutes elevates marker for brain damage 2Holding breath for several minutes elevates marker for brain damage 3Holding breath for several minutes elevates marker for brain damage 4La Jolla Institute discovers novel tumor suppressor 2La Jolla Institute discovers novel tumor suppressor 3
... Stem Cell Functional Identification Kit contains ... be used for the short-term maintenance, ... the induction of NSCs into astrocyte, ... panel consisting of mouse anti-human Nestin, ...
GM130 Immunogen: Recombinant purified rat GM130 Family / Subclass 1: Signal Transduction Storage: 4 C...
NATIVE RAT OSTEOCALCIN...
... x W x H): 17 3/4" ... lbsCapacity: 12 slidesTime: Programmable 0 - 100 ... and hybridization steps 40 user programmable protocols ... Fixed temperature) Rapid temperature ramp-up from 37 ...
Biology Products: